Key facts
- Notable investors include University of California, Maykr, San Diego.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Xzōm
- ·The full record, as it builds
Funding rounds
No funding rounds for Xzōm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xzōm
Developer of a rapid, point-of-care diagnostic platform designed to offer analysis that delivers accurate results. The company's platform provides a wide range of features like critical health insights, early detection, cross-functional collaboration, exosomal analysis, and sending diagnostic samples to large reference laboratories, empowering clinicians and patients with timely information to make critical health decisions.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2024
- Employees
- 35
- Website
- xzom.com/
- Ownership
- Privately Held (backing)
Xzōm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xzōm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xzōm in its N-PORT filings yet. We sweep new filings monthly.